© 2001 American Heart Association, Inc.
Molecular Medicine |
xIAP Induces Cell-Cycle Arrest and Activates Nuclear Factor-
B
New Survival Pathways Disabled by Caspase-Mediated Cleavage During Apoptosis of Human Endothelial Cells
From the Institute of Arteriosclerosis Research (B.L., K.K., J.-R.N., G.B.), Department of Pathology (H.A.B.), and Department of Cardiology and Angiology (G.B.), University of Münster, Münster, Germany, and Department of Pathology (K.J.G., N.F., E.W.R.), University of Washington, Seattle, Wash.
Correspondence to Elaine W. Raines, Department of Pathology, Harborview Medical Center, 325 9th Ave, Box 359675, Seattle, WA 98104-2499. E-mail ewraines{at}u.washington.edu
Abstract—Survival
of human vascular endothelial cells depends on their ability to
activate the transcription factor nuclear factor-
B (NF-B), a
regulator of antiapoptotic genes, such as the X chromosome–linked
inhibitor of apoptosis protein (xIAP). In the present study, we
demonstrated expression of xIAP in the endothelial lining of normal
human arteries and veins and elevated levels in highly malignant human
endothelial tumors. Using retroviral infection of human endothelial
cells, we identified two novel survival mechanisms mediated by xIAP in
endothelial cells. First, xIAP can activate the transcription factor
NF-B, a known survival factor for human endothelial cells. This
positive feedback loop induced by xIAP is mediated via phosphorylation
and sustained degradation of inhibitor (I) B
. Second, xIAP
can inhibit cell proliferation via downregulation of cyclins A and D1
and induction of the cyclin-dependent kinase inhibitors
p21Cip1/Waf1 and
p27Kip1. Cleavage of xIAP by caspases during
endothelial cell apoptosis disables both of these biological functions
of xIAP. Thus, caspase-mediated cleavage of xIAP interrupts a positive
regulatory cytoprotective loop between NF-B and xIAP and increases
the vulnerability of the cell to apoptosis by releasing it from an
xIAP-mediated quiescent
state.
Key Words: apoptosis • caspases • cleavage • retrovirus
This article has been cited by other articles:
 |
|
 |
|
  J. Kim, J. Park, S. Choi, S.-G. Chi, A. L. Mowbray, H. Jo, and H. Park X-Linked Inhibitor of Apoptosis Protein Is an Important Regulator of Vascular Endothelial Growth Factor-Dependent Bovine Aortic Endothelial Cell Survival Circ. Res., April 25, 2008; 102(8): 896 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Wilkinson, A. S. Wilkinson, S. Galban, R. A. Csomos, and C. S. Duckett Apoptosis-Inducing Factor Is a Target for Ubiquitination through Interaction with XIAP Mol. Cell. Biol., January 1, 2008; 28(1): 237 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Seligson, F. Hongo, S. Huerta-Yepez, Y. Mizutani, T. Miki, H. Yu, S. Horvath, D. Chia, L. Goodglick, and B. Bonavida Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer Recurrence Clin. Cancer Res., October 15, 2007; 13(20): 6056 - 6063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Harfouche and S. N. A. Hussain Signaling and regulation of endothelial cell survival by angiopoietin-2 Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1635 - H1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. von Wnuck Lipinski, P. Keul, N. Ferri, S. Lucke, G. Heusch, J. W. Fischer, and B. Levkau Integrin-Mediated Transcriptional Activation of Inhibitor of Apoptosis Proteins Protects Smooth Muscle Cells Against Apoptosis Induced by Degraded Collagen Circ. Res., June 23, 2006; 98(12): 1490 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. von Wnuck Lipinski, P. Keul, S. Lucke, G. Heusch, J. Wohlschlaeger, H. A. Baba, and B. Levkau Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells Cardiovasc Res, February 15, 2006; 69(3): 697 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zhang, H.-M. Shen, and C. N. Ong Down-regulation of c-FLIP contributes to the sensitization effect of 3,3'-diindolylmethane on TRAIL-induced apoptosis in cancer cells Mol. Cancer Ther., December 1, 2005; 4(12): 1972 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Re, R. K. Thomas, K. Behringer, and V. Diehl From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential Blood, June 15, 2005; 105(12): 4553 - 4560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Wilkinson, B. W. M. Richter, A. S. Wilkinson, E. Burstein, J. M. Rumble, B. Balliu, and C. S. Duckett VIAF, a Conserved Inhibitor of Apoptosis (IAP)-interacting Factor That Modulates Caspase Activation J. Biol. Chem., December 3, 2004; 279(49): 51091 - 51099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Schimmer Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice Cancer Res., October 15, 2004; 64(20): 7183 - 7190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Sharples, N. Patel, P. Brown, K. Stewart, H. Mota-Philipe, M. Sheaff, J. Kieswich, D. Allen, S. Harwood, M. Raftery, et al. Erythropoietin Protects the Kidney against the Injury and Dysfunction Caused by Ischemia-Reperfusion J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2115 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation J. Biol. Chem., June 4, 2004; 279(23): 24015 - 24023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lewis, E. Burstein, S. B. Reffey, S. B. Bratton, A. B. Roberts, and C. S. Duckett Uncoupling of the Signaling and Caspase-inhibitory Properties of X-linked Inhibitor of Apoptosis J. Biol. Chem., March 5, 2004; 279(10): 9023 - 9029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Z. Carter, S. M. Kornblau, T. Tsao, R.-Y. Wang, W. D. Schober, M. Milella, H.-G. Sung, J. C. Reed, and M. Andreeff Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis Blood, December 1, 2003; 102(12): 4179 - 4186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krajewska, S. Krajewski, S. Banares, X. Huang, B. Turner, L. Bubendorf, O.-P. Kallioniemi, A. Shabaik, A. Vitiello, D. Peehl, et al. Elevated Expression of Inhibitor of Apoptosis Proteins in Prostate Cancer Clin. Cancer Res., October 15, 2003; 9(13): 4914 - 4925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ferri, K. J. Garton, and E. W. Raines An NF-{kappa}B-dependent Transcriptional Program Is Required for Collagen Remodeling by Human Smooth Muscle Cells J. Biol. Chem., May 23, 2003; 278(22): 19757 - 19764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Z. Ammarguellat, P. O. Gannon, F. Amiri, and E. L. Schiffrin Fibrosis, Matrix Metalloproteinases, and Inflammation in the Heart of DOCA-Salt Hypertensive Rats: Role of ETA Receptors Hypertension, February 1, 2002; 39(2): 679 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Lee and T. Collins Nuclear Factor-{{kappa}}B and Cell Survival : IAPs Call for Support Circ. Res., February 16, 2001; 88(3): 262 - 264. [Full Text] [PDF]
|
|